EGFR and glioma: This observation is consistent with previous data on anti-EGFRvIII CAR-T cells secreting anti-EGFR-TCEs, which reduced viability of multiple EGFR+ EGFRvIII- glioma cell lines in a way that was not clearly related to the level of EGFR expression (5).